These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
142 related articles for article (PubMed ID: 8368730)
1. Genes coding for antigens recognized on human tumors by autologous cytolytic T lymphocytes. Coulie P; Weynants P; Muller C; Lehmann F; Herman J; Baurain JF; Boon T Ann N Y Acad Sci; 1993 Aug; 690():113-9. PubMed ID: 8368730 [No Abstract] [Full Text] [Related]
2. A new family of genes coding for an antigen recognized by autologous cytolytic T lymphocytes on a human melanoma. Van den Eynde B; Peeters O; De Backer O; Gaugler B; Lucas S; Boon T J Exp Med; 1995 Sep; 182(3):689-98. PubMed ID: 7544395 [TBL] [Abstract][Full Text] [Related]
3. Tumor antigens recognized by cytolytic T lymphocytes: present perspectives for specific immunotherapy. Boon T Int J Cancer; 1993 May; 54(2):177-80. PubMed ID: 8486420 [No Abstract] [Full Text] [Related]
4. Transfection and expression of a gene coding for a human melanoma antigen recognized by autologous cytolytic T lymphocytes. Traversari C; van der Bruggen P; Van den Eynde B; Hainaut P; Lemoine C; Ohta N; Old L; Boon T Immunogenetics; 1992; 35(3):145-52. PubMed ID: 1537606 [TBL] [Abstract][Full Text] [Related]
5. Genes coding for tumor rejection antigens: perspectives for specific immunotherapy. Boon T; Coulie P; Marchand M; Weynants P; Wölfel T; Brichard V Important Adv Oncol; 1994; ():53-69. PubMed ID: 8206495 [No Abstract] [Full Text] [Related]
6. Cytolytic T lymphocytes recognize an antigen encoded by MAGE-A10 on a human melanoma. Huang LQ; Brasseur F; Serrano A; De Plaen E; van der Bruggen P; Boon T; Van Pel A J Immunol; 1999 Jun; 162(11):6849-54. PubMed ID: 10352307 [TBL] [Abstract][Full Text] [Related]
7. Heterogeneity of clones from a human metastatic melanoma detected by autologous cytotoxic T lymphocyte clones. Anichini A; Fossati G; Parmiani G J Exp Med; 1986 Jan; 163(1):215-20. PubMed ID: 3484513 [TBL] [Abstract][Full Text] [Related]
8. A new tumor-specific antigenic peptide encoded by MAGE-6 is presented to cytolytic T lymphocytes by HLA-Cw16. Vantomme V; Boël P; De Plaen E; Boon T; van der Bruggen P Cancer Immun; 2003 Dec; 3():17. PubMed ID: 14664500 [TBL] [Abstract][Full Text] [Related]
9. Human tumour antigens recognized by T-cells: perspectives for new cancer vaccines. Van den Eynde B; Gaugler B; van der Bruggen P; Coulie P; Brichard V; Boon T Biochem Soc Trans; 1995 Aug; 23(3):681-6. PubMed ID: 8566443 [No Abstract] [Full Text] [Related]
10. A mutated intron sequence codes for an antigenic peptide recognized by cytolytic T lymphocytes on a human melanoma. Coulie PG; Lehmann F; Lethé B; Herman J; Lurquin C; Andrawiss M; Boon T Proc Natl Acad Sci U S A; 1995 Aug; 92(17):7976-80. PubMed ID: 7644523 [TBL] [Abstract][Full Text] [Related]
11. Human gene MAGE-3 codes for an antigen recognized on a melanoma by autologous cytolytic T lymphocytes. Gaugler B; Van den Eynde B; van der Bruggen P; Romero P; Gaforio JJ; De Plaen E; Lethé B; Brasseur F; Boon T J Exp Med; 1994 Mar; 179(3):921-30. PubMed ID: 8113684 [TBL] [Abstract][Full Text] [Related]
12. Clonal analysis of cytotoxic and regulatory T cell responses against human melanoma. Mukherji B; Guha A; Chakraborty NG; Sivanandham M; Nashed AL; Sporn JR; Ergin MT J Exp Med; 1989 Jun; 169(6):1961-76. PubMed ID: 2471770 [TBL] [Abstract][Full Text] [Related]
13. Induction of tumor-specific cytotoxic T lymphocytes in cancer patients by autologous tumor RNA-transfected dendritic cells. Nair SK; Morse M; Boczkowski D; Cumming RI; Vasovic L; Gilboa E; Lyerly HK Ann Surg; 2002 Apr; 235(4):540-9. PubMed ID: 11923611 [TBL] [Abstract][Full Text] [Related]
14. Genes coding for tumor-specific rejection antigens. Boon T; Van den Eynde B; Hirsch H; Moroni C; De Plaen E; van der Bruggen P; De Smet C; Lurquin C; Szikora JP; De Backer O Cold Spring Harb Symp Quant Biol; 1994; 59():617-22. PubMed ID: 7587121 [No Abstract] [Full Text] [Related]
15. Genes coding for melanoma antigens recognised by cytolytic T lymphocytes. De Smet C; Lurquin C; De Plaen E; Brasseur F; Zarour H; De Backer O; Coulie PG; Boon T Eye (Lond); 1997; 11 ( Pt 2)():243-8. PubMed ID: 9349420 [TBL] [Abstract][Full Text] [Related]
16. The tyrosinase gene codes for an antigen recognized by autologous cytolytic T lymphocytes on HLA-A2 melanomas. Brichard V; Van Pel A; Wölfel T; Wölfel C; De Plaen E; Lethé B; Coulie P; Boon T J Exp Med; 1993 Aug; 178(2):489-95. PubMed ID: 8340755 [TBL] [Abstract][Full Text] [Related]
17. Identification of a new peptide recognized by autologous cytolytic T lymphocytes on a human melanoma. Vigneron N; Ooms A; Morel S; Degiovanni G; Van Den Eynde BJ Cancer Immun; 2002 Jul; 2():9. PubMed ID: 12747754 [TBL] [Abstract][Full Text] [Related]
18. A gene encoding an antigen recognized by cytolytic T lymphocytes on a human melanoma. van der Bruggen P; Traversari C; Chomez P; Lurquin C; De Plaen E; Van den Eynde B; Knuth A; Boon T Science; 1991 Dec; 254(5038):1643-7. PubMed ID: 1840703 [TBL] [Abstract][Full Text] [Related]
19. Clinical trials with VMO for melanoma. Wallack MK; Sivanandham M Ann N Y Acad Sci; 1993 Aug; 690():178-89. PubMed ID: 8368736 [No Abstract] [Full Text] [Related]
20. T cell receptor (TCR) structure of autologous melanoma-reactive cytotoxic T lymphocyte (CTL) clones: tumor-infiltrating lymphocytes overexpress in vivo the TCR beta chain sequence used by an HLA-A2-restricted and melanocyte-lineage-specific CTL clone. Sensi M; Salvi S; Castelli C; Maccalli C; Mazzocchi A; Mortarini R; Nicolini G; Herlyn M; Parmiani G; Anichini A J Exp Med; 1993 Oct; 178(4):1231-46. PubMed ID: 8376931 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]